Overview:-
Human papillomavirus, commonly known as HPV, constitutes of more than 150 related viruses in a group. Every HPV virus is of unique kind with different numbers. These viruses attack on the specific squamous epithelial cells and survive on them. Certain types of the human papillomaviruses could lead to severe cancer types such as cancer of vagina, cervix, penis, anus, vulva, and some parts of throat and mouth. While other HPVs forms only non-cancerous tumours in the body. These viruses are mainly considered to be mucosal, as they are attracted to moisture and invade on the mucosal surfaces in the living cells. The risk of cervical cancer could be prevented by accurate treatment and diagnosis of the developing abnormal cells in the cervix. . There are two most usual tests applied to test the behavior of cervical cells including HPV and Pap tests.
Request for Analysis of COVID-19 Impact on HPV and Pap Testing Market –
https://www.coherentmarketinsights.com/insight/request-sample/1733
HPV testing is conducted to keep a check on HPV’s behaviour in the cervix that could result in cervical cancer. An effective screening is performed by simple smear test known as Pap testing to determine the normal or abnormal functioning of the cervical cells. If a person is detected with abnormal cells through Pap test is further evaluated with HPV testing for testing cervical cancer.
Market Drivers:-
The key factor that thrive growth of the HPV and Pap testing market is increasing prevalence of severe chronic diseases such as vaginal and cervical cancer. In 2017, the National Cervical Cancer Coalition reported that, the total numbers of women in the U.S., who are diagnosed with cervical cancer every year, are around 12,000. Moreover, the American Sexual Health Association (ASHA) claimed that cervical cancer is one of the most preventable cancer types amongst others. These cancers could be prevented at early stage immediately after detection. The abnormal cell in the cervix could be treated prior to the development of cervical cancerous cells so that it could be prevented.
Moreover, the improvement in existing accuracy of HPV testing with new product launches would thrive the global HPV and Pap testing market growth. For instance, the QIAsure Methylation Test was launched by QIAGEN N.V in June 2016 to determine cervical cancer development risk. .
Another factor to drive the market growth over the forecast period is advancements in technological diagnostics field. For instance, Home HPV Screening test was launched by Nurx, a consumer health and telemedicine company, on January 2019 that allowed women to conveniently test their risk for cervical cancer from home only at an affordable cost.
Request PDF Brochure Report –
https://www.coherentmarketinsights.com/insight/request-pdf/1733
Market Restrains:-
The only limitation that could hinder growth of the global HPV and Pap testing market is the low reliability of the outcomes as it shows inaccuracy in smear based Pap tests.
Key Players:-
The major players operating in the global HPV and Pap testing market consist of Seegene, Inc., Qiagen N.V., Hologic, Inc., Arbor Vita Corporation, Abbott Laboratories, Femasys, Inc., Becton, Dickinson & Company, Roche Diagnostics, Quest Diagnostics, Onco Health Corporation, and others.
Key players sustain their presence in the market by aiming at providing accurate and efficient tests at minimum prices. For instance, European CE Mark was received by Hologic, Inc. in April 2019 for developing ThinPrep Genesis processor in Europe. ThinPrep Genesis processor is a molecular sample system that has an automated cytology slide, which provides reliable and accurate results with increased operational efficiency. Moreover, FDA approval was received by Becton, Dickinson and Company in February 2018 for advancement of the BD Onclarity HPV assay, which identifies the high risk for cervical cancer in women with HPV genotypes.
Regional Analysis:-
The global HPV and Pap testing market is segmented on the basis of region into North America, Middle East, Asia Pacific, Europe, Latin America, and Africa. Among everyone, North America dominates the global HPV and Pap testing market and is anticipated to hold on its dominant position over the forecast period due to increasing number of cervical cancer cases in the U.S. For instance, the Centers for Disease Control and Prevention (CDC) reported in 2016 that the number of new cases of cervical cancer was around 12,984 in the U.S.
The government initiatives and various awareness campaigns regarding early cancer detection are creating high awareness among female population that fuels growth of the market. For instance, a non-profit organization named as UAB comprehensive care center promoted the use of preventive HPV vaccine by conducting an awareness program in January 2016 that explained about various benefits opted from vaccine to women health in the U.S.
Reasons to Purchase this Report
Current and future of global HPV and Pap Testing market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/1733
Market Taxonomy
On the basis of test type, the global HPV and Pap Testing Market is segmented into:
- HPV Test
- Pap Test
On the basis of application, the global HPV and Pap Testing Market is segmented into:
- Cervical Cancer
- Vaginal Cancer
On the basis of end user, the global HPV and Pap Testing Market is segmented into:
- Hospitals
- Diagnostic Centers
- Home Care Settings
- Others
On the basis of region, the global HPV and Pap Testing Market market is segmented into:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Major Point Answered in HPV and Pap Testing Market Research Study are:
What will be the progress rate of the HPV and Pap Testing Market for the conjecture period, 2020-2027?
What are the prominent factors driving the HPV and Pap Testing Market across different regions?
Who are the major vendors dominating the HPV and Pap Testing industry and what are their winning strategies?
What will be the market scope for the estimated period?
What are the major trends shaping the expansion of the industry in the coming years?
What are the challenges faced by the HPV and Pap Testing Market?
Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837